These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 11121661)

  • 1. Estimation of optimum dose per fraction for high LET radiations: implications for proton radiotherapy.
    Jones B; Dale RG
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1549-57. PubMed ID: 11121661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical radiobiology of proton therapy: modeling of RBE.
    Jones B
    Acta Oncol; 2017 Nov; 56(11):1374-1378. PubMed ID: 28820311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The assessment of RBE effects using the concept of biologically effective dose.
    Dale RG; Jones B
    Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):639-45. PubMed ID: 10078651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incorporation of the concept of minimum RBE (RbEmin) into the linear-quadratic model and the potential for improved radiobiological analysis of high-LET treatments.
    Carabe-Fernandez A; Dale RG; Jones B
    Int J Radiat Biol; 2007 Jan; 83(1):27-39. PubMed ID: 17357437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A model for the relative biological effectiveness of protons: the tissue specific parameter α/β of photons is a predictor for the sensitivity to LET changes.
    Wedenberg M; Lind BK; Hårdemark B
    Acta Oncol; 2013 Apr; 52(3):580-8. PubMed ID: 22909391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
    Ödén J; Eriksson K; Toma-Dasu I
    Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the Implications of a Variable RBE on Proton Dose Fractionation Across a Clinical Pencil Beam Scanned Spread-Out Bragg Peak.
    Marshall TI; Chaudhary P; Michaelidesová A; Vachelová J; Davídková M; Vondráček V; Schettino G; Prise KM
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):70-77. PubMed ID: 27084630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Radiobiology of Proton Therapy: Challenges and Opportunities Around Relative Biological Effectiveness.
    Jones B; McMahon SJ; Prise KM
    Clin Oncol (R Coll Radiol); 2018 May; 30(5):285-292. PubMed ID: 29454504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calculation of high-LET radiotherapy dose required for compensation of overall treatment time extensions.
    Jones B; Carabe-Fernandez A; Dale RG
    Br J Radiol; 2006 Mar; 79(939):254-7. PubMed ID: 16498040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton Treatment Techniques for Posterior Fossa Tumors: Consequences for Linear Energy Transfer and Dose-Volume Parameters for the Brainstem and Organs at Risk.
    Giantsoudi D; Adams J; MacDonald SM; Paganetti H
    Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):401-410. PubMed ID: 27986346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative biological effectiveness (RBE) values for proton beam therapy.
    Paganetti H; Niemierko A; Ancukiewicz M; Gerweck LE; Goitein M; Loeffler JS; Suit HD
    Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):407-21. PubMed ID: 12023146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of variable RBE on proton fractionation.
    Dasu A; Toma-Dasu I
    Med Phys; 2013 Jan; 40(1):011705. PubMed ID: 23298075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploration and application of phenomenological RBE models for proton therapy.
    Rørvik E; Fjæra LF; Dahle TJ; Dale JE; Engeseth GM; Stokkevåg CH; Thörnqvist S; Ytre-Hauge KS
    Phys Med Biol; 2018 Sep; 63(18):185013. PubMed ID: 30102240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiobiology with heavy charged particles: a historical review.
    Skarsgard LD
    Phys Med; 1998 Jul; 14 Suppl 1():1-19. PubMed ID: 11542635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer.
    Paganetti H
    Phys Med Biol; 2014 Nov; 59(22):R419-72. PubMed ID: 25361443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable RBE in proton therapy: comparison of different model predictions and their influence on clinical-like scenarios.
    Giovannini G; Böhlen T; Cabal G; Bauer J; Tessonnier T; Frey K; Debus J; Mairani A; Parodi K
    Radiat Oncol; 2016 May; 11():68. PubMed ID: 27185038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The minimal FLASH sparing effect needed to compensate the increase of radiobiological damage due to hypofractionation for late-reacting tissues.
    Böhlen TT; Germond JF; Bourhis J; Bailat C; Bochud F; Moeckli R
    Med Phys; 2022 Dec; 49(12):7672-7682. PubMed ID: 35933554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redefining relative biological effectiveness in the context of the EQDX formalism: implications for alpha-particle emitter therapy.
    Hobbs RF; Howell RW; Song H; Baechler S; Sgouros G
    Radiat Res; 2014 Jan; 181(1):90-8. PubMed ID: 24502376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the dose-averaged LET a reliable predictor for the relative biological effectiveness?
    Grün R; Friedrich T; Traneus E; Scholz M
    Med Phys; 2019 Feb; 46(2):1064-1074. PubMed ID: 30565705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determining RBE for development of lung fibrosis induced by fractionated irradiation with carbon ions utilizing fibrosis index and high-LET BED model.
    Zhou C; Jones B; Moustafa M; Yang B; Brons S; Cao L; Dai Y; Schwager C; Chen M; Jaekel O; Chen L; Debus J; Abdollahi A
    Clin Transl Radiat Oncol; 2019 Jan; 14():25-32. PubMed ID: 30511024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.